DrMatthew Lewis

UK Consortium for MetAbolic Phenotyping (MAP/UK) - Our mission is to advance metabolic phenotyping for the benefit of UK scientists by driving cooperation, collaborative development, and education among UK research institutions. The overarching goal of the partnership is to develop, optimise, transfer, harmonise and validate efficient and high-quality research methods and training, specifically tailored to application in molecular epidemiology, clinical medicine, and understanding disease mechanisms, to meet the growing need of biomedical studies that require metabolic phenotyping.

Metabolomics Quality Assurance & Quality Control Consortium (mQACC) - The consortium’s mission is to engage the metabolomics community to communicate and promote the development, dissemination and harmonization of best QA/QC practices in untargeted metabolomics through the following objectives: To identify, catalog, harmonize and disseminate QA/QC best practices for untargeted metabolomics. To establish mechanisms to enable the metabolomics community to adopt QA/QC best practices. To promote and support systematic training in QA/QC best practices for the metabolomics community. To encourage the prioritization and development of reference materials applicable to metabolomics research.